Similar articles

• [Gene therapy for brain tumors using herpes simplex virus vector].

  Toda M. Toda M. Nihon Rinsho. 2005 Sep;63 Suppl 9:510-4. Nihon Rinsho. 2005. PMID: 16201573 Review. Japanese. No abstract available.
• Gene transfer with herpes simplex vectors.

  Lachmann RH, Efstathiou S. Lachmann RH, et al. Curr Opin Mol Ther. 1999 Oct;1(5):622-32. Curr Opin Mol Ther. 1999. PMID: 11249669 Review.
• Tissue-specific expression of herpes simplex virus thymidine kinase gene delivered by adeno-associated virus inhibits the growth of human hepatocellular carcinoma in athymic mice.

  Su H, Lu R, Chang JC, Kan YW. Su H, et al. Proc Natl Acad Sci U S A. 1997 Dec 9;94(25):13891-6. doi: 10.1073/pnas.94.25.13891. Proc Natl Acad Sci U S A. 1997. PMID: 9391123 Free PMC article.
• Effective treatment of tumors with strong beta-catenin/T-cell factor activity by transcriptionally targeted oncolytic herpes simplex virus vector.

  Kuroda T, Rabkin SD, Martuza RL. Kuroda T, et al. Cancer Res. 2006 Oct 15;66(20):10127-35. doi: 10.1158/0008-5472.CAN-06-2744. Cancer Res. 2006. PMID: 17047077
• Enhancement of gene therapy specificity for diffuse colon carcinoma liver metastases with recombinant herpes simplex virus.

  Carroll NM, Chiocca EA, Takahashi K, Tanabe KK. Carroll NM, et al. Ann Surg. 1996 Sep;224(3):323-9; discussion 329-30. doi: 10.1097/00000658-199609000-00008. Ann Surg. 1996. PMID: 8813260 Free PMC article.